SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-105033
Filing Date
2024-04-22
Accepted
2024-04-22 17:07:08
Documents
19
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d799475d10ka.htm   iXBRL 10-K/A 337147
2 EX-10.12 d799475dex1012.htm EX-10.12 12886
3 EX-31.3 d799475dex313.htm EX-31.3 3472
4 EX-31.4 d799475dex314.htm EX-31.4 3515
  Complete submission text file 0001193125-24-105033.txt   606094

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nerv-20231231.xsd EX-101.SCH 4973
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20231231_cal.xml EX-101.CAL 975
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20231231_def.xml EX-101.DEF 3275
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20231231_lab.xml EX-101.LAB 23042
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20231231_pre.xml EX-101.PRE 18433
23 EXTRACTED XBRL INSTANCE DOCUMENT d799475d10ka_htm.xml XML 8774
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36517 | Film No.: 24861941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)